Ryszard Smolarczyk Selected Research

Melphalan (Alkeran)

1/2014

Synthesis and analysis of activity of a potential anti-melanoma prodrug with a hydrazine linker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryszard Smolarczyk Research Topics

Disease

29	Neoplasms (Cancer) 01/2023 - 03/2005
19	Melanoma (Melanoma, Malignant) 01/2023 - 01/2006
4	Hypoxia (Hypoxemia) 01/2021 - 01/2018
3	Necrosis 08/2021 - 04/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2006
2	Bites and Stings (Sting) 01/2023 - 10/2022
1	Squamous Cell Carcinoma of Head and Neck 06/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Bone Diseases (Bone Disease) 01/2023
1	Infections 10/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2022
1	Multiple Myeloma 01/2021
1	Vascular Tissue Neoplasms 06/2020
1	Peripheral Arterial Disease 11/2019
1	Carcinoma (Carcinomatosis) 02/2019
1	Nasopharyngeal Carcinoma 06/2010
1	Hemolysis 06/2010
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2005
1	Cystic Fibrosis (Mucoviscidosis) 03/2005

Drug/Important Bio-Agent (IBA)

6	Interleukin-12 (IL 12)IBA 01/2021 - 06/2010
6	Peptides (Polypeptides)IBA 11/2016 - 01/2006
4	CytokinesIBA 06/2023 - 05/2006
4	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 03/2005
4	Therapeutic UsesIBA 01/2021 - 05/2006
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2009
3	vadimezanIBA 08/2021 - 01/2018
3	EnzymesIBA 12/2020 - 12/2006
2	InterferonsIBA 01/2023 - 10/2022
2	Oxygen (Dioxygen)IBA 01/2021 - 06/2019
2	Heme Oxygenase-1IBA 12/2020 - 12/2006
2	VaccinesIBA 06/2020 - 12/2015
2	Digoxin (Digitek)FDA LinkGeneric 03/2020 - 01/2018
2	Folic Acid (Vitamin M)FDA LinkGeneric 02/2019 - 06/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 06/2010
2	hydrazine (hydrazine dihydrochloride)IBA 01/2014 - 07/2009
2	ProdrugsIBA 01/2014 - 07/2009
2	HMGB1 Protein (HMG1)IBA 11/2012 - 10/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 05/2006
1	ChemokinesIBA 06/2023
1	fosbretabulin (combretastatin A4)IBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	ResveratrolIBA 10/2022
1	PolyphenolsIBA 10/2022
1	SeleniumIBA 10/2022
1	Vitamin E FDA LinkGeneric 10/2022
1	QuercetinIBA 10/2022
1	FlavonoidsIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	daratumumabIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	betulinIBA 02/2019
1	Phosphates (Orthophosphate)IBA 02/2019
1	DNA VaccinesIBA 01/2018
1	EndoglinIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	sialorphinIBA 11/2016
1	glutaminyl- arginyl- phenylalanyl- seryl- arginineIBA 11/2016
1	Antimicrobial PeptidesIBA 11/2016
1	Heat Shock Transcription FactorsIBA 02/2015
1	VinculinIBA 02/2015
1	PhosphatidylserinesIBA 08/2014
1	D-K6L9 peptideIBA 08/2014
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 08/2014
1	InterleukinsIBA 04/2014
1	Recombinant ProteinsIBA 04/2014
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2014
1	Melphalan (Alkeran)FDA LinkGeneric 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2014
1	vasostatinIBA 01/2012
1	OligopeptidesIBA 06/2010
1	Liposomes (Liposome)IBA 06/2010
1	Antineoplastic Agents (Antineoplastics)IBA 07/2009
1	Levodopa (L Dopa)FDA LinkGeneric 07/2009
1	Monophenol Monooxygenase (Tyrosinase)IBA 07/2009
1	Carbidopa (Lodosyn)FDA LinkGeneric 07/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2006
1	Integrin alphaVbeta3IBA 01/2006
1	AlbuminsIBA 03/2005

Therapy/Procedure

17	Therapeutics 01/2023 - 01/2006
5	Radiotherapy 06/2023 - 01/2018
3	Immunotherapy 01/2023 - 01/2021
3	Brachytherapy 08/2021 - 06/2020
1	Donor Selection 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Drug Therapy (Chemotherapy) 01/2018
1	Injections 06/2010
1	Subcutaneous Injections 12/2006